Literature DB >> 21621453

Computerized detection of adverse drug reactions in the medical intensive care unit.

Sandra L Kane-Gill1, Shyam Visweswaran, Melissa I Saul, An-Kwok Ian Wong, Louis E Penrod, Steven M Handler.   

Abstract

OBJECTIVE: Clinical event monitors are a type of active medication monitoring system that can use signals to alert clinicians to possible adverse drug reactions. The primary goal was to evaluate the positive predictive values of select signals used to automate the detection of ADRs in the medical intensive care unit.
METHOD: This is a prospective, case series of adult patients in the medical intensive care unit during a six-week period who had one of five signals presents: an elevated blood urea nitrogen, vancomycin, or quinidine concentration, or a low sodium or glucose concentration. Alerts were assessed using 3 objective published adverse drug reaction determination instruments. An event was considered an adverse drug reaction when 2 out of 3 instruments had agreement of possible, probable or definite. Positive predictive values were calculated as the proportion of alerts that occurred, divided by the number of times that alerts occurred and adverse drug reactions were confirmed.
RESULTS: 145 patients were eligible for evaluation. For the 48 patients (50% male) having an alert, the mean±SD age was 62±19 years. A total of 253 alerts were generated. Positive predictive values were 1.0, 0.55, 0.38 and 0.33 for vancomycin, glucose, sodium, and blood urea nitrogen, respectively. A quinidine alert was not generated during the evaluation.
CONCLUSIONS: Computerized clinical event monitoring systems should be considered when developing methods to detect adverse drug reactions as part of intensive care unit patient safety surveillance systems, since they can automate the detection of these events using signals that have good performance characteristics by processing commonly available laboratory and medication information.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21621453      PMCID: PMC3139253          DOI: 10.1016/j.ijmedinf.2011.04.005

Source DB:  PubMed          Journal:  Int J Med Inform        ISSN: 1386-5056            Impact factor:   4.046


  50 in total

Review 1.  Simplified pharmacoeconomics of critical care and severe sepsis.

Authors:  Frank R Ernst; Howard Levy; Rebecca L Qualy
Journal:  J Intensive Care Med       Date:  2007 Sep-Oct       Impact factor: 3.510

Review 2.  Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists.

Authors:  Michael Rybak; Ben Lomaestro; John C Rotschafer; Robert Moellering; William Craig; Marianne Billeter; Joseph R Dalovisio; Donald P Levine
Journal:  Am J Health Syst Pharm       Date:  2009-01-01       Impact factor: 2.637

Review 3.  An approach to the evaluation and documentation of adverse drug reaction.

Authors:  C L Goh
Journal:  Singapore Med J       Date:  1989-06       Impact factor: 1.858

4.  Predictive value of alert triggers for identification of developing adverse drug events.

Authors:  Carlton Moore; Jiang Li; Chang-Chiao Hung; John Downs; Jonathan R Nebeker
Journal:  J Patient Saf       Date:  2009-12       Impact factor: 2.844

Review 5.  Principles and practices of medication safety in the ICU.

Authors:  Sandra Kane-Gill; Robert J Weber
Journal:  Crit Care Clin       Date:  2006-04       Impact factor: 3.598

6.  Reevaluating the safety profile of pediatrics: a comparison of computerized adverse drug event surveillance and voluntary reporting in the pediatric environment.

Authors:  Jeffrey Ferranti; Monica M Horvath; Heidi Cozart; Julie Whitehurst; Julie Eckstrand
Journal:  Pediatrics       Date:  2008-05       Impact factor: 7.124

Review 7.  Detecting adverse events for patient safety research: a review of current methodologies.

Authors:  Harvey J Murff; Vimla L Patel; George Hripcsak; David W Bates
Journal:  J Biomed Inform       Date:  2003 Feb-Apr       Impact factor: 6.317

8.  Can surveillance systems identify and avert adverse drug events? A prospective evaluation of a commercial application.

Authors:  Ashish K Jha; Julia Laguette; Andrew Seger; David W Bates
Journal:  J Am Med Inform Assoc       Date:  2008-06-25       Impact factor: 4.497

9.  Mississippi mud no more: cost-effectiveness of pharmacokinetic dosage adjustment of vancomycin to prevent nephrotoxicity.

Authors:  William Darko; Joseph J Medicis; Adrienne Smith; Roy Guharoy; David E Lehmann
Journal:  Pharmacotherapy       Date:  2003-05       Impact factor: 4.705

10.  Prevention of adverse drug events through computerized surveillance.

Authors:  R S Evans; S L Pestotnik; D C Classen; S B Bass; J P Burke
Journal:  Proc Annu Symp Comput Appl Med Care       Date:  1992
View more
  14 in total

1.  Comparison of three pharmacovigilance algorithms in the ICU setting: a retrospective and prospective evaluation of ADRs.

Authors:  Sandra L Kane-Gill; Elizabeth A Forsberg; Margaret M Verrico; Steven M Handler
Journal:  Drug Saf       Date:  2012-08-01       Impact factor: 5.606

2.  Medication safety and knowledge-based functions: a stepwise approach against information overload.

Authors:  Andrius Patapovas; Harald Dormann; Brita Sedlmayr; Melanie Kirchner; Anja Sonst; Fabian Müller; Barbara Pfistermeister; Bettina Plank-Kiegele; Renate Vogler; Renke Maas; Manfred Criegee-Rieck; Hans-Ulrich Prokosch; Thomas Bürkle
Journal:  Br J Clin Pharmacol       Date:  2013-09       Impact factor: 4.335

3.  Clinical evaluation of the ADE scorecards as a decision support tool for adverse drug event analysis and medication safety management.

Authors:  Werner O Hackl; Elske Ammenwerth; Romaric Marcilly; Emmanuel Chazard; Michel Luyckx; Pascale Leurs; Regis Beuscart
Journal:  Br J Clin Pharmacol       Date:  2013-09       Impact factor: 4.335

4.  A Multicenter Evaluation of Off-Label Medication Use and Associated Adverse Drug Reactions in Adult Medical ICUs.

Authors:  Pamela L Smithburger; Mitchell S Buckley; Mark A Culver; Sarah Sokol; Ishaq Lat; Steven M Handler; Levent Kirisci; Sandra L Kane-Gill
Journal:  Crit Care Med       Date:  2015-08       Impact factor: 7.598

5.  Real-time pharmacy surveillance and clinical decision support to reduce adverse drug events in acute kidney injury: a randomized, controlled trial.

Authors:  Allison B McCoy; Zachary L Cox; Erin B Neal; Lemuel R Waitman; Neeraja B Peterson; Gautam Bhave; Edward D Siew; Ioana Danciu; Julia B Lewis; Josh F Peterson
Journal:  Appl Clin Inform       Date:  2012-06-13       Impact factor: 2.342

6.  AKI in low-risk versus high-risk patients in intensive care.

Authors:  Florentina E Sileanu; Raghavan Murugan; Nicole Lucko; Gilles Clermont; Sandra L Kane-Gill; Steven M Handler; John A Kellum
Journal:  Clin J Am Soc Nephrol       Date:  2014-11-25       Impact factor: 8.237

7.  Risk factors for acute kidney injury in older adults with critical illness: a retrospective cohort study.

Authors:  Sandra L Kane-Gill; Florentina E Sileanu; Raghavan Murugan; Gregory S Trietley; Steven M Handler; John A Kellum
Journal:  Am J Kidney Dis       Date:  2014-12-06       Impact factor: 8.860

8.  Using a Clinical Surveillance System to Detect Drug-Associated Hypoglycemia in Nursing Home Residents.

Authors:  Colleen M Culley; Subashan Perera; Zachary A Marcum; Sandra L Kane-Gill; Steven M Handler
Journal:  J Am Geriatr Soc       Date:  2015-10-12       Impact factor: 5.562

9.  Adverse drug reactions in therapeutic hypothermia after cardiac arrest.

Authors:  Robert Witcher; Amy L Dzierba; Catherine Kim; Pamela L Smithburger; Sandra L Kane-Gill
Journal:  Ther Adv Drug Saf       Date:  2016-11-29

10.  Outcomes and Adverse Effects With Peramivir for the Treatment of Influenza H1N1 in Critically Ill Pediatric Patients.

Authors:  Robert Witcher; Joanna Tracy; Laura Santos; Arun Chopra
Journal:  J Pediatr Pharmacol Ther       Date:  2019 Nov-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.